Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride

    • Product Name (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride
    • Alias (S)-ANB-HCl
    • Einecs 629-813-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    423411

    Product Name (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride
    Cas Number 114612-98-1
    Molecular Formula C14H16ClNO2
    Molecular Weight 265.74
    Appearance White to off-white solid
    Purity ≥98%
    Melting Point 220-228°C (dec.)
    Solubility Soluble in water
    Optical Activity Specific rotation (α)D20 = +19° (c=1, H2O)
    Storage Temperature 2-8°C (refrigerated)
    Synonyms S-β-(2-Naphthyl)-alanine hydrochloride
    Iupac Name (S)-3-amino-4-(naphthalen-2-yl)butanoic acid hydrochloride

    As an accredited (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 5g amber glass vial with a white screw cap, labeled with the chemical name, formula, CAS number, and hazard warnings.
    Shipping (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride is shipped in secure, chemical-resistant packaging to prevent leakage or contamination. It is transported under ambient conditions, compliant with safety regulations for non-hazardous materials. A certificate of analysis and safety data sheet are included to ensure safe and traceable handling during transit.
    Storage (S)-3-Amino-4-(2-Naphthyl)butanoic acid hydrochloride should be stored in a tightly sealed container, protected from light and moisture. Keep the substance at a temperature between 2–8°C (refrigerated). Ensure it is stored in a dry, well-ventilated area, away from incompatible substances such as strong oxidizers. Follow all local regulations and guidelines for the storage of laboratory chemicals.
    Application of (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride

    Applications of (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride in Industrial Manufacturing

    (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride serves critical roles as a chiral intermediate in specialized chemical industries. Its high enantiomeric purity and naphthyl structure enable value-adding transformations that meet the exact standards of downstream manufacturers. As the original manufacturer, we supply this material to regulated applications spanning active pharmaceutical ingredient (API) synthesis, peptide drug R&D, chiral auxiliaries for fine chemicals, and select diagnostic reagent manufacturing. Below are the key industrial applications, covering distinct compliance, formulation, process, and end product requirements for each segment.

    1. API Intermediate for Anticancer Drug Synthesis

    Many pharmaceutical manufacturers use this compound as a building block during the multi-step synthesis of specific chiral anticancer agents. In these high-value workflows, formulators rely on its stereochemical integrity for essential coupling or elongation reactions. Its hydrochloride salt form improves solubility and handling during GMP-compliant manufacturing. The material typically enters after early-stage alkylation and before final heterocycle formation, requiring chromatography-based purity verification at each step. APIs produced from this route must conform to stringent ICH and local pharmacopeia specifications.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP/NF (United States Pharmacopeia/National Formulary) monograph requirements for APIs
    • EU GMP Part II (ICH GMP for APIs)
    • FDA 21 CFR Part 210/211 for drug substance manufacture

    Typical usage ratio

    • 0.5–3.5 molar equivalents relative to primary substrate, depending on the stage of API synthesis and required yield.
    • Formulators adjust the ratio based on target molecule complexity and side reaction risk.

    Downstream process integration

    • Added during the chiral amination or chain elongation step.
    • May require intermediate purification via reversed-phase HPLC before final API derivatization.
    • Incorporated under inert gas conditions to maintain stereopurity.

    Final product types

    • Chiral anticancer drug intermediates
    • Final active pharmaceutical ingredients (APIs) for oncology use
    • Small-molecule kinase inhibitors

    2. Key Component in Peptide Drug Development

    Biotech R&D divisions employ this material to introduce non-natural amino acid residues into synthetic peptide chains. Such modification enhances target selectivity or metabolic stability of peptide therapeutics. The hydrochloride form supports high-purity solid-phase peptide synthesis (SPPS) via Fmoc or Boc chemistry. Rigorous documentation is required to track its chiral configuration and batch-level characterization, which impacts both process reproducibility and final clinical trial submission.

    Industry compliance standards

    • ISO 13485: Quality management for medical devices and peptides
    • Ph. Eur. (European Pharmacopoeia) standards for peptide drugs
    • US FDA guidelines for IND enabling synthetic peptides
    • ICH Q11: Development and Manufacture of Drug Substances

    Typical usage ratio

    • Insertion at 1 residue per targeted modification site, typically < 5% of total peptide chain length.
    • Ratio may increase in high-purity analog development or when required by biological target optimization.

    Downstream process integration

    • Introduced during automated SPPS chain assembly at required sequence position.
    • Protected with orthogonal groups for stepwise solid support coupling.
    • Final deprotection and HPLC purification applied before lyophilization.

    Final product types

    • Synthetic peptide drug candidates
    • Peptide-based research tools for target validation
    • Preclinical peptide APIs

    3. Chiral Auxiliary for Fine Chemical Synthesis

    In advanced fine chemical manufacturing, chemists take advantage of the high enantiomeric purity of this compound to induce stereoselectivity in asymmetric syntheses. It acts as a transient chiral auxiliary, facilitating enantioselective alkylations or Michael additions for producing value-added building blocks. Detailed specification control is essential, especially in markets where trace impurities or racemization affect downstream product registration.

    Industry compliance standards

    • REACH (EC No 1907/2006) for chemical registration in the EU
    • ISO 9001: Quality management certification for chemical synthesis
    • Custom specifications by multinational chemical clients
    • Japanese Chemical Substances Control Law (CSCL)

    Typical usage ratio

    • As a chiral auxiliary, used at 0.8–1.1 stoichiometric equivalent per asymmetric center.
    • Recyclable in some processes, with actual input adjusted based on yield and auxiliary recovery efficiency.

    Downstream process integration

    • Attached to substrate via amide or ester linkage prior to the asymmetric transformation.
    • Removal and recovery post-reaction with mild hydrolysis or reductive cleavage.
    • Continuous in-process quality testing for enantiomeric excess.

    Final product types

    • Chiral building blocks for agrochemicals
    • Optically pure specialty monomers
    • Intermediates for flavors and fragrances

    4. Precursor for Diagnostic Reagent Manufacturing

    This compound functions as a high-purity precursor in the synthesis of certain fluorescent or absorption-labeled diagnostic reagents. Its stable amine and aromatic backbone enable site-specific conjugation with reporter groups, supporting sensitive biomarker assays used by clinical and laboratory diagnostics firms. Quality batches must meet release criteria for purity, identity, and absence of interfering contaminants that could impair assay performance under ISO-accredited production.

    Industry compliance standards

    • ISO 13485: Medical device and diagnostic reagent quality system
    • ISO 9001: Process traceability and documentation
    • IVDR (In Vitro Diagnostic Regulation, EU 2017/746)
    • CLSI (Clinical and Laboratory Standards Institute) guidelines

    Typical usage ratio

    • Commonly 1.0–1.5 equivalents in molar conjugation reactions to maximize reporter ligation.
    • Excess limited to prevent downstream signal background or non-specific assay binding.

    Downstream process integration

    • Introduced in solution-phase amidation or carbodiimide coupling with reporter tags.
    • Purified by preparative LC or precipitation to meet device-grade standards.
    • QC includes batch-specific impurity analysis and performance testing in prototype assay.

    Final product types

    • Fluorescent or chromogenic biosensor reagents
    • Enzyme-linked immunoassay (ELISA) reporters
    • Diagnostic peptide or protein conjugates
    Free Quote

    Competitive (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride

    Quality-Driven Synthesis for Advanced Laboratories

    Over the years, our facility has spent considerable effort refining the synthesis of (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride. Delivering this specialty building block in high purity allows researchers to focus on biological studies without distraction from inconsistent batches. Our production team uses precise, reproducible methods that support stereochemical integrity, maintaining the (S)-configuration required for serious scientific work.

    Model, Form, and Specifications Forged by Demand

    Through requests from pharmaceutical developers and peptide research groups, we chose to focus on providing (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride as a crystalline hydrochloride salt. This format handles well, dissolves efficiently in both water and typical organic solvents, and shows long shelf stability when stored as recommended. During each run, our QC lab screens for enantiopurity by chiral HPLC, and we confirm the absence of major side products through modern spectrometric and chromatographic analysis.

    Purity targets remain steady above 98% by assay. Moisture content, measured by Karl Fischer titration, is kept below established thresholds based on repeated stability testing. We issue certificates of analysis for every batch, tying the finished product's assays to our production records and daily monitoring logs. All specifications arise from our direct experiences troubleshooting and optimizing yield, flow, and filtration steps, not from guesswork or generic technical sheets.

    Usage Guided by The Needs of Discovery

    Chemists working with this molecule usually pursue peptide modifications, receptor binding studies, or exploratory drug designs. We’re aware because our technical teams field questions about compatibility with common coupling methods, protection strategies for the amino group, and preferred storage conditions. Researchers often use (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride as an analog of natural amino acids, inserting the naphthyl ring to probe structure–activity relationships or add aromatic bulk.

    Solid-phase synthesis protocols report good results with its hydrochloride form because the salt delivers a stable, solid substrate with reliable solubility profiles. In solution-phase contexts, the compound supports productive amide bond formation and resists racemization under most standard conditions. Unlike some substituted amino acids, which can show poor compatibility with peptide purification columns, this hydrochloride salt elutes cleanly without significant tailing or protein contamination.

    Outside peptide chemistry, academic groups used our product to add chiral centers in model compounds for asymmetric catalysis benchmarks. Our technical archive tracks published reaction routes, including hydrogenation, condensation, and cross-coupling exploits, which reference our material by batch. Through feedback and collaborations, we’ve deepened our understanding of reactive compatibility in different solvents and pH.

    Differences Born from Direct Production Experience

    From experience, we notice a few practical advantages when providing the hydrochloride over the free base. The hydrochloride salt form remains manageable even at scale, avoiding issues common to hygroscopic free bases or sticky, oily residue that complicates weighing and transfer. Handling safety also improves, since hydrochloride salts suppress dust and provide a clearer end-of-trituration endpoint during crystallization steps. Shipments reach international labs with materials holding their reported purity, without surprises attributable to air or light instability.

    Competing products often reach us as technical samples containing detectable free acid or base. Our difference stems from hands-on batch monitoring with a focus on phase-appropriate acidification. Whether starting from chiral precursors or resolving racemates, each lot commands close attention—from temperature control in cyclization to pH adjustment at final isolation. As a manufacturer, we know subtle changes translate to real bottlenecks in end-user labs, especially those running sensitive LC-MS or NMR.

    We never rely on merely passing a single purity threshold. Each critical parameter, including heavy metal content, solvent residues, and optical rotation, comes into focus through our team’s full exposure to pre- and post-purification analytics. Our teams have trained on crystallization failures, odd color formation, and the subtleties of removing stubborn side fractions. The understanding developed from seeing hundreds of runs gives us the confidence to stand behind the quality of what leaves our facility.

    Some will ask how our product compares to similar aromatic-substituted amino acids, such as those bearing biphenyl or phenanthryl side chains. From our experience at the bench and in scale-up tanks, the naphthyl variant offers a blend of robust aromatic stacking and manageable reactivity. Our QC samples demonstrate greater consistency in melting point and enantiomeric purity, and chemical compatibility with peptide ligation chemistry in both public and proprietary projects. Our hydrochloride salt dissolves rapidly without leaving cloudiness or residue, matching the needs of analytical and preparative sciences.

    Supporting Facts from Daily Operations

    Precision follows from deep familiarity with the tools and raw materials. Nearly every step in our process, from column chromatography to lyophilization, reflects adjustments honed over repeat batches. Investment in fresh chiral columns and rapid spectroscopic identification tools shortened troubleshooting when odd contaminants crept in. Real-world feedback, not just theoretical knowledge, drives our production team to document every shift, batch-to-batch deviation, and unexpected result before product release.

    Customers value transparency because lingering uncertainty on raw material quality slows research and saps project momentum. Our facility’s process captures extensive batch traceability so customers can connect any deviation in downstream experiments to a concrete lot number and assay value. Our hands-on work with regulatory submissions means we understand the issues customers face validating new methods for pharmacopeia-grade amino acid derivatives.

    End-User Solutions Shaped by Real Outcomes

    Lab teams confronted by slow dissolving, poor handling, or racemization have called to report delays and rework. By developing protocols to minimize these problems, we’ve built practical answers into our product supply. If a researcher struggles to integrate our hydrochloride salt into semi-automated peptide synthesis runs, we direct them to our documented batch histories and storage recommendations, sometimes even proposing adjustments based on lessons learned from years of troubleshooting.

    To overcome bottlenecks inherent in scaling aromatic chiral amino acids, our chemists reengineered key steps to limit side-product formation, removing the need for extensive downstream purification. This emphasis on root-cause process improvement rather than quick cosmetic fixes stems directly from our years producing for customers who cannot afford to risk their own results on unstable supply. Our technical colleagues appreciate that direct feedback on impurities or handling quirks finds a place in our refinement cycle, closing the loop between users, analytics, and production.

    Shipping schedules match the chemical’s inherent shelf-stability, and our warehouse keeps careful inventory movement logs reviewed against real-time sensor feeds for temperature and humidity. We’ve traced improved user outcomes to these operational precautions, especially in samples sent to humid or hot climates. Our solution arises from a commitment to hands-on monitoring and rapid course correction rather than theoretical modeling.

    Ongoing Engagement with Research and Industry

    We maintain close relationships with peptide synthesis labs, interdisciplinary medicinal chemistry teams, and academic collaborators. Sharing detailed usage notes alongside each shipment means new customers benefit from accumulated knowledge. When questions arise about coupling agent compatibility or chromatographic response, our technical team refers to internal research and feedback to shape actionable suggestions—not generic advice, but direct answers stemming from tested protocols and repeated experience.

    Through interacting with regulatory teams supporting INDs and patent submissions, we collect data on the impact of even minor analytical deviations. Meeting those demands means increased investment in routine calibration, extensive control sample usage, and deliberate avoidance of statistical “averaging-out” that can mask outliers in chiral purity or residual solvent content. Our operation thrives on unfiltered exposure to the challenges real scientists face at the bench.

    Improvement Built from Feedback, Not Just Data Points

    Problems encountered at scale often take on a different character than those in bench-top runs. Feedback from manufacturing chemists processing kilograms highlighted issues with bulk density, caking, or flowability we had not observed in smaller lots. Each cycle of production brought new learning, whether during rotary evaporation, vacuum filtration, or large-batch recrystallization. Tweaking variables from stirring speed to anti-caking agent addition follows naturally from this direct exposure.

    Customers who previously switched from other suppliers cited batch-to-batch instability manifesting in variable color, odour, or dissolution times. Our response was to step up in-process controls and bring in outside reference standards, whenever standard assays flagged unusual trends. Such experience-driven changes mean we can supply an amino acid hydrochloride that stands up to real-world demands in laboratory or pilot plant settings, not just idealized small-scale tests.

    Solving problems together with scientists at the bench forms a feedback-rich cycle, as every new attempt brings insight into the strengths and blind spots in our synthesis. The common theme in our iterative process lies in using direct experience—for example, odd clumping noticed in samples pressed for tabletization led our team to evaluate both particle size and crystal habit, applying fixes before making broader stock changes. Solutions come not from speculation, but from continuous, eyes-open observation.

    Commitment Backed by Evidence

    Anyone can promise “high quality,” but building a reputation comes from delivering material that advances rather than holds back complex scientific exploration. We enter every batch with the accumulated insights from line chemists, process engineers, and front-line QC analysts. Each year brings new analytical capabilities, more robust isolation techniques, and time-saving tweaks suggested by the slow, detailed work of hands-on production and real communication with customers.

    Peptide chemists and pharmaceutical researchers choose our (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride because it shows up on time, pure, and ready for challenging applications. In side-by-side trial observations at our collaborating sites, scientists have reported better coupling yields and less rework stemming from unexpected impurities. Their ability to move forward efficiently confirms to us, as manufacturers, that our boots-on-the-ground approach works, not just in theory but through thousands of vials and flasks in real labs.

    Trust Earned Through Real Performance

    Consistent results build trust in a world of rising material complexity. Long hours spent refining our method and troubleshooting rare failure modes mean our hydrochloride salt supports lab schedules, critical research, and urgent development goals without introducing unforeseen variables. The value added by hands-on manufacturing and transparent technical support, grounded in repeatable data, matters more than claims written by distant marketers. Through ongoing engagement, documented accuracy, and openness about what works and what still needs adjustment, we keep driving improvement in every shipment.

    Our experience producing and distributing (S)-3-Amino-4-(2-Naphthyl)Butanoic Acid Hydrochloride flows through the daily routine of our chemists and process team. By collecting and acting on feedback, reviewing real-time data, and applying hard-earned lessons from bench to bulk bin, we stand by the product’s ability to meet the evolving needs of research and manufacturing. With each new breakthrough achieved by our customers, we see proof that deep, practical expertise offers the most stable path forward for specialty building blocks in modern chemistry.